Skip to main content
. 2018 Mar 29;39(5):858–865. doi: 10.1038/aps.2018.1

Figure 3.

Figure 3

Treatment with DCPIB reduced brain infarct volume of neonatal hypoxic-ischemic (HI) brain injury in vivo. (A) Representative 2,3,5-triphenyltetrazolium chloride (TTC) images of the infarcts of the coronal sections of P8 mouse pup brains treated with vehicle (control HI group) or 10 mg/kg DCPIB (DCPIB-treated HI group). (B) Column chart summarizing that animals in the DCPIB-treated HI group (n=13) had significantly reduced brain infarct volume compared to those in the control HI group (n=23; *P<0.05; Student's t-test).